Latest Headlines

  1. Nucleus Biologics Becomes First Custom Cell Culture Media Company To Achieve EXCiPACT Certification For The Manufacture Of Excipient GMP Quality Cell Culture Media, Supplements, And Buffers 1/9/2025

    Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS.

  2. CRB Announces Exhibition And Speaker Schedule For Advanced Therapies Week 2025 1/9/2025

    Attending the show? Make sure to meet CRB’s team of cell and gene therapy specialists at Advanced Therapies Week in booth 566. CRB’s subject matter expert, Peter Walters, will be presenting an educational seminar in the session “Developing Future Facilities While Supporting the Advanced Therapies Ecosystem."

  3. Abzena Strengthens Board With Appointment Of Biopharma Industry Leader, Dr. Moncef Slaoui 1/8/2025
    Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Moncef Slaoui, Ph.D., to its Board of Directors.

  4. AES Clean Technology Names Former CRB Executive To Drive Western Region Growth 12/20/2024

    AES Clean Technology, a leading provider of high-performance cleanroom facilities, has today announced the appointment of Jeff Rozelle as Senior Vice President of Business Development, West Region.

  5. Abzena Expands Analytical Capabilities To Include GMP Cell-Based Potency Testing Across US & UK Sites 11/19/2024

    Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced the expansion of their early and late phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, UK and San Diego, CA development and manufacturing facilities.

  6. MilliporeSigma Invests $76 Million To Expand ADC Manufacturing For Novel Cancer Therapies 11/6/2024

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced a $76 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri. This investment will triple existing capacity and enhance the company’s contract development and manufacturing organization (CDMO) offering, reinforcing its commitment to clients and patients.

  7. Abzena Announces Major Expansion In Microbiology Laboratory Space In Support Of Biologic Manufacturing 10/30/2024
  8. Accelerate Antibody Capture With Sartobind® Rapid A Lab For Fast, Flexible, And Future-Proof Affinity Chromatography 10/28/2024

    The life science group Sartorius is launching Sartobind® Rapid A Lab, the latest innovation in our portfolio of laboratory separation technologies. Featuring the fastest Protein A matrix on the market, this groundbreaking affinity chromatography unit is set to deliver unparalleled productivity and transform antibody purification processes.

  9. SMC Pharma Services Enters Autoinjector Development Agreement With A Biopharmaceutical Company For The Bios Platform 10/21/2024

    SMC Pharma Services has partnered with a biopharmaceutical company to develop an autoinjector platform solution for a rare disease clinical trial.

  10. BD And ten23 health® Partner To Advance Efficiency And Quality In Aseptic Manufacturing With RFID-Enabled Prefillable Syringes 10/8/2024

    BD (Becton, Dickinson and Company) and ten23 health announced a collaboration to develop a new way to track refillable syringes using RFID technology.